Evidence map›Paper›PMID 39553230›Full record

ArticleAmerican journal of cancer research2024

Comprehensive analysis of the oncogenic potential of eukaryotic initiation factor 3M via SAAL1 interaction in lung adenocarcinoma.

Hung-Hsing Chiang, Kuan-Li Wu, Hung-Pei Tsai, Chai-Tung Ong, Chao-Yuan Chang, Yu-Yuan Wu, Tzu-Yen Shen, Jen-Yu Hung, Hsiao-Chen Lee, Ya-Ling Hsu and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hung-Hsing ChiangDivision of Thoracic Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University Kaohsiung 807, Taiwan.
Kuan-Li WuGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University Kaohsiung 807, Taiwan.
Hung-Pei TsaiDivision of Neurosurgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University Kaohsiung 807, Taiwan.
Chai-Tung OngGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University Kaohsiung 807, Taiwan.
Chao-Yuan ChangPost Baccalaureat Medicine, College of Medicine, Kaohsiung Medical University Kaohsiung 807, Taiwan.
Yu-Yuan WuGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University Kaohsiung 807, Taiwan.
Tzu-Yen ShenSchool of Medicine, College of Medicine, Taipei Medical University Taipei 110, Taiwan.
Jen-Yu HungDrug Development and Value Creation Research Center, Kaohsiung Medical University Kaohsiung 807, Taiwan.
Hsiao-Chen LeeDivision of Plastic Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University Kaohsiung 807, Taiwan.
Ya-Ling HsuGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University Kaohsiung 807, Taiwan.
Ying-Ming TsaiDrug Development and Value Creation Research Center, Kaohsiung Medical University Kaohsiung 807, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung adenocarcinoma (LUAD) carries a poor prognosis at advanced stages underscoring the need to elucidate the underlying molecular mechanisms driving its pathogenesis. This study aimed to investigate the roles of eukaryotic translation initiation factor 3 subunit M (

Indexed as

EIF3MJMJD1Clung adenocarcinomaSAAL1

Identifiers

PMID39553230
PMCPMC11560815

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.